{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:21:11Z","timestamp":1787610071571,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172241 and 82341066"],"award-info":[{"award-number":["82172241 and 82341066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.1038\/s41388-026-03920-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:41:47Z","timestamp":1785159707000},"page":"3736-3748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The epigenetic KMT5C-HDAC1 axis promotes hepatocellular carcinoma stemness and progression through SERPINA4 repression and chromatin compaction"],"prefix":"10.1038","volume":"45","author":[{"given":"Hongbin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caini","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pangfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiping","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8707-1775","authenticated-orcid":false,"given":"Zhiju","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-2700","authenticated-orcid":false,"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"3920_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6.","journal-title":"Nat Rev Dis Prim"},{"key":"3920_CR2","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1172\/JCI66024","volume":"123","author":"T Yamashita","year":"2013","unstructured":"Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest. 2013;123:1911\u20138.","journal-title":"J Clin Invest"},{"key":"3920_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1101\/gad.351444.123","volume":"38","author":"MA Honer","year":"2024","unstructured":"Honer MA, Ferman BI, Gray ZH, Bondarenko EA, Whetstine JR. Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. Genes Dev. 2024;38:473\u2013503.","journal-title":"Genes Dev"},{"key":"3920_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","volume":"21","author":"S Zhao","year":"2021","unstructured":"Zhao S, Allis CD, Wang GG. The language of chromatin modification in human cancers. Nat Rev Cancer. 2021;21:413\u201330.","journal-title":"Nat Rev Cancer"},{"key":"3920_CR5","doi-asserted-by":"publisher","first-page":"e183391","DOI":"10.1172\/JCI183391","volume":"134","author":"S Gold","year":"2024","unstructured":"Gold S, Shilatifard A. Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges. J Clin Invest. 2024;134:e183391.","journal-title":"J Clin Invest"},{"key":"3920_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41576-023-00666-x","volume":"25","author":"S Gourisankar","year":"2024","unstructured":"Gourisankar S, Krokhotin A, Wenderski W, Crabtree GR. Context-specific functions of chromatin remodellers in development and disease. Nat Rev Genet. 2024;25:340\u201361.","journal-title":"Nat Rev Genet"},{"key":"3920_CR7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1101\/gad.300704","volume":"18","author":"G Schotta","year":"2004","unstructured":"Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 2004;18:1251\u201362.","journal-title":"Genes Dev"},{"key":"3920_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1053\/j.gastro.2022.10.036","volume":"164","author":"V Boonsanay","year":"2023","unstructured":"Boonsanay V, Mosa MH, Looso M, Weichenhan D, Ceteci F, Pudelko L, et al. Loss of SUV420H2-dependent chromatin compaction drives right-sided colon cancer progression. Gastroenterology. 2023;164:214\u201327.","journal-title":"Gastroenterology"},{"key":"3920_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22589","volume":"9","author":"S Phoyen","year":"2023","unstructured":"Phoyen S, Sanpavat A, Ma-On C, Stein U, Hirankarn N, Tangkijvanich P, et al. H4K20me3 upregulated by reactive oxygen species is associated with tumor progression and poor prognosis in patients with hepatocellular carcinoma. Heliyon. 2023;9:e22589.","journal-title":"Heliyon"},{"key":"3920_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/HEP.0000000000000559","volume":"80","author":"Y Tong","year":"2024","unstructured":"Tong Y, Wang F, Li S, Guo W, Li Q, Qian Y, et al. Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors. Hepatology. 2024;80:38\u201354.","journal-title":"Hepatology"},{"key":"3920_CR11","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/1878-0261.12963","volume":"15","author":"H Chen","year":"2021","unstructured":"Chen H, Nio K, Yamashita T, Okada H, Li R, Suda T, et al. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma. Mol Oncol. 2021;15:2203\u201318.","journal-title":"Mol Oncol"},{"key":"3920_CR12","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1053\/jhep.2002.33683","volume":"35","author":"K Yasui","year":"2002","unstructured":"Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, et al. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology. 2002;35:1476\u201384.","journal-title":"Hepatology"},{"key":"3920_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1101\/gad.210377.112","volume":"27","author":"M Hahn","year":"2013","unstructured":"Hahn M, Dambacher S, Dulev S, Kuznetsova AY, Eck S, Worz S, et al. Suv4-20h2 mediates chromatin compaction and is important for cohesin recruitment to heterochromatin. Genes Dev. 2013;27:859\u201372.","journal-title":"Genes Dev"},{"key":"3920_CR14","doi-asserted-by":"publisher","first-page":"e168375","DOI":"10.1172\/jci.insight.168375","volume":"8","author":"J Chen","year":"2023","unstructured":"Chen J, Xu Z, Huang H, Tang Y, Shan H, Xiao F. SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. JCI Insight. 2023;8:e168375.","journal-title":"JCI Insight"},{"key":"3920_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.stem.2019.04.017","volume":"24","author":"B Artegiani","year":"2019","unstructured":"Artegiani B, van Voorthuijsen L, Lindeboom RGH, Seinstra D, Heo I, Tapia P, et al. Probing the tumor suppressor function of BAP1 in CRISPR-engineered human liver organoids. Cell Stem Cell. 2019;24:927\u2013943.e926.","journal-title":"Cell Stem Cell"},{"key":"3920_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nchembio.2282","volume":"13","author":"KD Bromberg","year":"2017","unstructured":"Bromberg KD, Mitchell TR, Upadhyay AK, Jakob CG, Jhala MA, Comess KM, et al. The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity. Nat Chem Biol. 2017;13:317\u201324.","journal-title":"Nat Chem Biol"},{"key":"3920_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163\u201373.","journal-title":"Lancet"},{"key":"3920_CR18","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1080\/15548627.2024.2358732","volume":"20","author":"W Zhang","year":"2024","unstructured":"Zhang W, Tang Y, Yang P, Chen Y, Xu Z, Qi C, et al. TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy. Autophagy. 2024;20:2146\u201363.","journal-title":"Autophagy"},{"key":"3920_CR19","doi-asserted-by":"publisher","first-page":"gkae1223","DOI":"10.1093\/nar\/gkae1223","volume":"53","author":"DM English","year":"2024","unstructured":"English DM, Lee SN, Sabat KA, Baker IM, Pham TK, Collins MO, et al. Rapid degradation of histone deacetylase 1 (HDAC1) reveals essential roles in both gene repression and active transcription. Nucleic Acids Res. 2024;53:gkae1223.","journal-title":"Nucleic Acids Res"},{"key":"3920_CR20","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1073\/pnas.95.7.3519","volume":"95","author":"CA Hassig","year":"1998","unstructured":"Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, et al. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci USA. 1998;95:3519\u201324.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3920_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf8405","volume":"10","author":"X Xu","year":"2024","unstructured":"Xu X, Fang M, Chen L, Huang H, Dai ZM, Yang J, et al. Nzf2 promotes oligodendrocyte differentiation and regeneration via repressing HDAC1-mediated histone deacetylation. Sci Adv. 2024;10:eadf8405.","journal-title":"Sci Adv"},{"key":"3920_CR22","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u2013D646.","journal-title":"Nucleic Acids Res"},{"key":"3920_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1128\/MCB.18.2.790","volume":"18","author":"DC Schonwasser","year":"1998","unstructured":"Schonwasser DC, Marais RM, Marshall CJ, Parker PJ. Activation of the mitogen-activated protein kinase\/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol. 1998;18:790\u20138.","journal-title":"Mol Cell Biol"},{"key":"3920_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/oxfordjournals.jbchem.a003272","volume":"132","author":"S Nakashima","year":"2002","unstructured":"Nakashima S. Protein kinase C alpha (PKC alpha): regulation and biological function. J Biochem. 2002;132:669\u201375.","journal-title":"J Biochem"},{"key":"3920_CR25","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1084\/jem.20160935","volume":"214","author":"L Bakiri","year":"2017","unstructured":"Bakiri L, Hamacher R, Grana O, Guio-Carrion A, Campos-Olivas R, Martinez L, et al. Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation. J Exp Med. 2017;214:1387\u2013409.","journal-title":"J Exp Med"},{"key":"3920_CR26","doi-asserted-by":"publisher","first-page":"23435","DOI":"10.1074\/jbc.272.37.23435","volume":"272","author":"JM Muller","year":"1997","unstructured":"Muller JM, Krauss B, Kaltschmidt C, Baeuerle PA, Rupec RA. Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway. J Biol Chem. 1997;272:23435\u20139.","journal-title":"J Biol Chem"},{"key":"3920_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11010-013-1654-2","volume":"379","author":"J Zhang","year":"2013","unstructured":"Zhang J, Yang Z, Li P, Bledsoe G, Chao L, Chao J. Kallistatin antagonizes Wnt\/beta-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6. Mol Cell Biochem. 2013;379:295\u2013301.","journal-title":"Mol Cell Biochem"},{"key":"3920_CR28","doi-asserted-by":"publisher","first-page":"24859","DOI":"10.1073\/pnas.1919766117","volume":"117","author":"LL Tseng","year":"2020","unstructured":"Tseng LL, Cheng HH, Yeh TS, Huang SC, Syu YY, Chuu CP, et al. Targeting the histone demethylase PHF8-mediated PKCalpha-Src-PTEN axis in HER2-negative gastric cancer. Proc Natl Acad Sci USA. 2020;117:24859\u201366.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3920_CR29","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1083\/jcb.201705031","volume":"217","author":"M Viotti","year":"2018","unstructured":"Viotti M, Wilson C, McCleland M, Koeppen H, Haley B, Jhunjhunwala S, et al. SUV420H2 is an epigenetic regulator of epithelial\/mesenchymal states in pancreatic cancer. J Cell Biol. 2018;217:763\u201377.","journal-title":"J Cell Biol"},{"key":"3920_CR30","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1158\/0008-5472.CAN-20-0821","volume":"82","author":"AS Pal","year":"2022","unstructured":"Pal AS, Agredo A, Lanman NA, Son J, Sohal IS, Bains M, et al. Loss of KMT5C promotes EGFR inhibitor resistance in NSCLC via LINC01510-mediated upregulation of MET. Cancer Res. 2022;82:1534\u201347.","journal-title":"Cancer Res"},{"key":"3920_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41421-023-00573-9","volume":"9","author":"J Li","year":"2023","unstructured":"Li J, Lu L, Liu L, Ren X, Chen J, Yin X, et al. HDAC1\/2\/3 are major histone desuccinylases critical for promoter desuccinylation. Cell Discov. 2023;9:85.","journal-title":"Cell Discov"},{"key":"3920_CR32","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051009","volume":"22","author":"L Zorro Shahidian","year":"2021","unstructured":"Zorro Shahidian L, Haas M, Le Gras S, Nitsch S, Mourao A, Geerlof A, et al. Succinylation of H3K122 destabilizes nucleosomes and enhances transcription. EMBO Rep. 2021;22:e51009.","journal-title":"EMBO Rep"},{"key":"3920_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/hep.27558","volume":"61","author":"X Zhi","year":"2015","unstructured":"Zhi X, Lin L, Yang S, Bhuvaneshwar K, Wang H, Gusev Y, et al. betaII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology. 2015;61:598\u2013612.","journal-title":"Hepatology"},{"key":"3920_CR34","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood-2002-01-0185","volume":"100","author":"RQ Miao","year":"2002","unstructured":"Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 2002;100:3245\u201352.","journal-title":"Blood"},{"key":"3920_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10120-017-0787-5","volume":"21","author":"C Ma","year":"2018","unstructured":"Ma C, Luo C, Yin H, Zhang Y, Xiong W, Zhang T, et al. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion. Gastric Cancer. 2018;21:617\u201331.","journal-title":"Gastric Cancer"},{"key":"3920_CR36","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1128\/MCB.25.16.6964-6979.2005","volume":"25","author":"G Bossis","year":"2005","unstructured":"Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, Rodriguez M, et al. Down-regulation of c-Fos\/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol. 2005;25:6964\u201379.","journal-title":"Mol Cell Biol"},{"key":"3920_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/1568009622666220428111327","volume":"22","author":"J Guo","year":"2022","unstructured":"Guo J, Zhao J, Xu Q, Huang D. Resistance of lenvatinib in hepatocellular carcinoma. Curr Cancer Drug Targets. 2022;22:865\u201378.","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03920-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03920-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03920-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:03:13Z","timestamp":1787608993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03920-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":37,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["3920"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03920-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}